FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093105444> ?p ?o ?g. }

• W2093105444 endingPage "12902" @default.
• W2093105444 startingPage "12897" @default.
• W2093105444 abstract "The successful lowering of the intracellular concentration of multidrug resistance (MDR)-type drugs by P-glycoprotein (Pgp) relies on its ability to overcome the passive influx rate of each MDR-type drug. Thus, the aim of the present work was to study the effect of passive transbilayer drug movement on the multidrug resistance and its modulation. Fluorescence quenching studies indicated that whereas the Pgp substrate rhodamine 123 traverses an artificial lipid membrane with a lifetime of 3 min, the transbilayer movement rate of the MDR modulators, quinidine and quinine, was too fast to be detected with present methods. Transbilayer movement rates of drugs and modulators were estimated from their equilibration rate throughout artificial multilamellar vesicles. The equilibration rate of five selected modulators was faster than the equilibration rate of five representative MDR-type drugs tested, which was comparable with the rate of rhodamine 123 equilibration. Moreover, the carrier-type peptide ionophore, valinomycin, which is freely mobile in the membrane, inhibited Pgp-mediated efflux of rhodamine 123 from MDR cells. In contrast, the channel-forming ionophore gramicidin D, a Pgp substrate that flip-flops slowly across the membrane, did not modulate cellular Pgp activity. Pgp, with a turnover number of about 900 min−1 can keep pace with the influx of an MDR-drug like rhodamine 123 exhibiting a transbilayer movement with a lifetime of minutes. On the other hand, Pgp would fail to protect MDR cells against cytotoxic drugs that are freely mobile through biological membranes and that re-enter cells faster than their Pgp-mediated active efflux rate. The relatively fast transbilayer movement exhibited by MDR modulators suggest that in contrast to MDR-type drugs, MDR modulators traverse the plasma membrane faster than the maximal expulsion rate of Pgp. The successful lowering of the intracellular concentration of multidrug resistance (MDR)-type drugs by P-glycoprotein (Pgp) relies on its ability to overcome the passive influx rate of each MDR-type drug. Thus, the aim of the present work was to study the effect of passive transbilayer drug movement on the multidrug resistance and its modulation. Fluorescence quenching studies indicated that whereas the Pgp substrate rhodamine 123 traverses an artificial lipid membrane with a lifetime of 3 min, the transbilayer movement rate of the MDR modulators, quinidine and quinine, was too fast to be detected with present methods. Transbilayer movement rates of drugs and modulators were estimated from their equilibration rate throughout artificial multilamellar vesicles. The equilibration rate of five selected modulators was faster than the equilibration rate of five representative MDR-type drugs tested, which was comparable with the rate of rhodamine 123 equilibration. Moreover, the carrier-type peptide ionophore, valinomycin, which is freely mobile in the membrane, inhibited Pgp-mediated efflux of rhodamine 123 from MDR cells. In contrast, the channel-forming ionophore gramicidin D, a Pgp substrate that flip-flops slowly across the membrane, did not modulate cellular Pgp activity. Pgp, with a turnover number of about 900 min−1 can keep pace with the influx of an MDR-drug like rhodamine 123 exhibiting a transbilayer movement with a lifetime of minutes. On the other hand, Pgp would fail to protect MDR cells against cytotoxic drugs that are freely mobile through biological membranes and that re-enter cells faster than their Pgp-mediated active efflux rate. The relatively fast transbilayer movement exhibited by MDR modulators suggest that in contrast to MDR-type drugs, MDR modulators traverse the plasma membrane faster than the maximal expulsion rate of Pgp." @default.
• W2093105444 created "2016-06-24" @default.
• W2093105444 creator A5012998533 @default.
• W2093105444 creator A5013852274 @default.
• W2093105444 creator A5028367995 @default.
• W2093105444 creator A5070479890 @default.
• W2093105444 date "1996-05-01" @default.
• W2093105444 modified "2023-10-17" @default.
• W2093105444 title "The Role of Passive Transbilayer Drug Movement in Multidrug Resistance and Its Modulation" @default.
• W2093105444 cites W1487550059 @default.
• W2093105444 cites W1502235918 @default.
• W2093105444 cites W1526872663 @default.
• W2093105444 cites W1565284520 @default.
• W2093105444 cites W1580223876 @default.
• W2093105444 cites W1599886286 @default.
• W2093105444 cites W1608154971 @default.
• W2093105444 cites W1970762986 @default.
• W2093105444 cites W1973889696 @default.
• W2093105444 cites W1982133643 @default.
• W2093105444 cites W1986639571 @default.
• W2093105444 cites W1991851546 @default.
• W2093105444 cites W1996172536 @default.
• W2093105444 cites W2006656480 @default.
• W2093105444 cites W2024437663 @default.
• W2093105444 cites W2025470299 @default.
• W2093105444 cites W2032736075 @default.
• W2093105444 cites W2033547045 @default.
• W2093105444 cites W2044569715 @default.
• W2093105444 cites W2051631129 @default.
• W2093105444 cites W2057061887 @default.
• W2093105444 cites W2063553083 @default.
• W2093105444 cites W2076672515 @default.
• W2093105444 cites W2081538957 @default.
• W2093105444 cites W2118234018 @default.
• W2093105444 cites W2318659424 @default.
• W2093105444 cites W35929032 @default.
• W2093105444 cites W4229652886 @default.
• W2093105444 doi "https://doi.org/10.1074/jbc.271.22.12897" @default.
• W2093105444 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8662680" @default.
• W2093105444 hasPublicationYear "1996" @default.
• W2093105444 type Work @default.
• W2093105444 sameAs 2093105444 @default.
• W2093105444 citedByCount "163" @default.
• W2093105444 countsByYear W20931054442012 @default.
• W2093105444 countsByYear W20931054442013 @default.
• W2093105444 countsByYear W20931054442014 @default.
• W2093105444 countsByYear W20931054442015 @default.
• W2093105444 countsByYear W20931054442016 @default.
• W2093105444 countsByYear W20931054442017 @default.
• W2093105444 countsByYear W20931054442018 @default.
• W2093105444 countsByYear W20931054442019 @default.
• W2093105444 countsByYear W20931054442020 @default.
• W2093105444 countsByYear W20931054442021 @default.
• W2093105444 countsByYear W20931054442022 @default.
• W2093105444 countsByYear W20931054442023 @default.
• W2093105444 crossrefType "journal-article" @default.
• W2093105444 hasAuthorship W2093105444A5012998533 @default.
• W2093105444 hasAuthorship W2093105444A5013852274 @default.
• W2093105444 hasAuthorship W2093105444A5028367995 @default.
• W2093105444 hasAuthorship W2093105444A5070479890 @default.
• W2093105444 hasBestOaLocation W20931054441 @default.
• W2093105444 hasConcept C12554922 @default.
• W2093105444 hasConcept C133936738 @default.
• W2093105444 hasConcept C181911157 @default.
• W2093105444 hasConcept C185592680 @default.
• W2093105444 hasConcept C200082930 @default.
• W2093105444 hasConcept C2778385715 @default.
• W2093105444 hasConcept C2778589691 @default.
• W2093105444 hasConcept C2778707650 @default.
• W2093105444 hasConcept C2779014961 @default.
• W2093105444 hasConcept C2780339425 @default.
• W2093105444 hasConcept C41625074 @default.
• W2093105444 hasConcept C501593827 @default.
• W2093105444 hasConcept C55493867 @default.
• W2093105444 hasConcept C79879829 @default.
• W2093105444 hasConcept C86803240 @default.
• W2093105444 hasConcept C98274493 @default.
• W2093105444 hasConceptScore W2093105444C12554922 @default.
• W2093105444 hasConceptScore W2093105444C133936738 @default.
• W2093105444 hasConceptScore W2093105444C181911157 @default.
• W2093105444 hasConceptScore W2093105444C185592680 @default.
• W2093105444 hasConceptScore W2093105444C200082930 @default.
• W2093105444 hasConceptScore W2093105444C2778385715 @default.
• W2093105444 hasConceptScore W2093105444C2778589691 @default.
• W2093105444 hasConceptScore W2093105444C2778707650 @default.
• W2093105444 hasConceptScore W2093105444C2779014961 @default.
• W2093105444 hasConceptScore W2093105444C2780339425 @default.
• W2093105444 hasConceptScore W2093105444C41625074 @default.
• W2093105444 hasConceptScore W2093105444C501593827 @default.
• W2093105444 hasConceptScore W2093105444C55493867 @default.
• W2093105444 hasConceptScore W2093105444C79879829 @default.
• W2093105444 hasConceptScore W2093105444C86803240 @default.
• W2093105444 hasConceptScore W2093105444C98274493 @default.
• W2093105444 hasIssue "22" @default.
• W2093105444 hasLocation W20931054441 @default.
• W2093105444 hasOpenAccess W2093105444 @default.
• W2093105444 hasPrimaryLocation W20931054441 @default.
• W2093105444 hasRelatedWork W1972428908 @default.

• next